Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	serine hydrolase activity	PCSK2 SEC11C ADAM8 RHBDD1 PRSS12 PRSS56 HTRA4 LIPE GZMM CTSS	7.65e-05	212	207	10	GO:0017171
GeneOntologyMolecularFunction	guanosine phosphorylase activity	PNP LACC1	1.07e-04	2	207	2	GO:0047975
GeneOntologyMolecularFunction	endopeptidase activity	PCSK2 SEC11C ADAM8 PHEX ADAMTS17 USP7 NAPSA RHBDD1 PRSS12 PRSS56 NLRP1 HTRA4 GZMM CTSS	1.67e-04	430	207	14	GO:0004175
GeneOntologyMolecularFunction	serine-type endopeptidase activity	PCSK2 SEC11C ADAM8 RHBDD1 PRSS12 PRSS56 HTRA4 GZMM CTSS	1.69e-04	190	207	9	GO:0004252
GeneOntologyMolecularFunction	purine-nucleoside phosphorylase activity	PNP LACC1	3.19e-04	3	207	2	GO:0004731
GeneOntologyMolecularFunction	serine-type peptidase activity	PCSK2 SEC11C ADAM8 RHBDD1 PRSS12 PRSS56 HTRA4 GZMM CTSS	3.20e-04	207	207	9	GO:0008236
GeneOntologyMolecularFunction	flavin adenine dinucleotide binding	ACADVL ILVBL AIFM2 AIFM1 MTRR ACOXL	4.41e-04	94	207	6	GO:0050660
GeneOntologyMolecularFunction	platelet-activating factor acetyltransferase activity	PAFAH1B2 PAFAH1B3	6.33e-04	4	207	2	GO:0047179
GeneOntologyMolecularFunction	electron-transferring-flavoprotein dehydrogenase activity	AIFM2 AIFM1	6.33e-04	4	207	2	GO:0004174
GeneOntologyMolecularFunction	beta-adrenergic receptor kinase activity	GRK2 GRK3	6.33e-04	4	207	2	GO:0047696
Domain	LamG	GAS6 CNTNAP3 NRXN2 LAMA2 COL5A3 COL18A1 EYS CSPG4	2.41e-08	44	206	8	SM00282
Domain	Laminin_G	GAS6 CNTNAP3 NRXN2 LAMA2 COL5A3 COL18A1 EYS CSPG4	2.28e-07	58	206	8	IPR001791
Domain	Laminin_G_2	GAS6 CNTNAP3 NRXN2 LAMA2 COL5A3 EYS CSPG4	2.46e-07	40	206	7	PF02210
Domain	LAM_G_DOMAIN	GAS6 CNTNAP3 NRXN2 LAMA2 EYS CSPG4	3.44e-06	38	206	6	PS50025
Domain	Laminin_G_1	GAS6 LAMA2 EYS CSPG4	4.46e-06	11	206	4	PF00054
Domain	Dynamin_central	DNM1 DNM2 DNM3	2.58e-05	6	206	3	IPR000375
Domain	GED	DNM1 DNM2 DNM3	2.58e-05	6	206	3	SM00302
Domain	Dynamin_M	DNM1 DNM2 DNM3	2.58e-05	6	206	3	PF01031
Domain	GED_dom	DNM1 DNM2 DNM3	2.58e-05	6	206	3	IPR020850
Domain	GED	DNM1 DNM2 DNM3	2.58e-05	6	206	3	PS51388
Domain	Dynamin_GTPase_CS	DNM1 DNM2 DNM3	2.58e-05	6	206	3	IPR019762
Domain	GED	DNM1 DNM2 DNM3	2.58e-05	6	206	3	PF02212
Domain	GED	DNM1 DNM2 DNM3	2.58e-05	6	206	3	IPR003130
Domain	G_DYNAMIN_1	DNM1 DNM2 DNM3	4.48e-05	7	206	3	PS00410
Domain	DYNc	DNM1 DNM2 DNM3	4.48e-05	7	206	3	SM00053
Domain	Cadherin_tail	PCDHGA9 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA1	5.09e-05	37	206	5	PF15974
Domain	Cadherin_CBD	PCDHGA9 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA1	5.09e-05	37	206	5	IPR031904
Domain	PH	PLEKHM1 GRK2 GRK3 DNM1 FERMT2 DNM2 PRKD2 IQSEC3 ARHGAP23 PREX2 PLCD3 DNM3	6.35e-05	278	206	12	SM00233
Domain	PH_DOMAIN	PLEKHM1 GRK2 GRK3 DNM1 FERMT2 DNM2 PRKD2 IQSEC3 ARHGAP23 PREX2 PLCD3 DNM3	6.57e-05	279	206	12	PS50003
Domain	PH_domain	PLEKHM1 GRK2 GRK3 DNM1 FERMT2 DNM2 PRKD2 IQSEC3 ARHGAP23 PREX2 PLCD3 DNM3	6.80e-05	280	206	12	IPR001849
Domain	PH_dom-like	APBB3 LYST PLEKHM1 MTMR11 GRK2 GRK3 DNM1 FERMT2 DNM2 PRKD2 IQSEC3 ARHGAP23 PREX2 PLCD3 DNM3	8.08e-05	426	206	15	IPR011993
Domain	-	GAS6 CNTNAP3 NRXN2 LAMA2 COL5A3 EYS CSPG4	8.72e-05	95	206	7	2.60.120.200
Domain	Cadherin_C	PCDHGA9 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA1	9.49e-05	42	206	5	IPR032455
Domain	Cadherin_C_2	PCDHGA9 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA1	9.49e-05	42	206	5	PF16492
Domain	EGF-like_dom	GAS6 CNTNAP3 ADAM8 FBLN2 NRXN2 C6 STAB2 LAMA2 EYS MEGF8 NAGPA	1.05e-04	249	206	11	IPR000742
Domain	EGF_1	GAS6 CNTNAP3 ADAM8 FBLN2 NRXN2 C6 STAB2 LAMA2 EYS MEGF8 NAGPA	1.29e-04	255	206	11	PS00022
Domain	EGF-like_CS	GAS6 CNTNAP3 ADAM8 FBLN2 NRXN2 C6 STAB2 LAMA2 EYS MEGF8 NAGPA	1.58e-04	261	206	11	IPR013032
Domain	ConA-like_dom	GAS6 CNTNAP3 NRXN2 MAMDC2 LAMA2 COL5A3 MAMDC4 COL18A1 EYS CSPG4	1.65e-04	219	206	10	IPR013320
Domain	EGF_2	GAS6 CNTNAP3 ADAM8 FBLN2 NRXN2 C6 STAB2 LAMA2 EYS MEGF8 NAGPA	1.81e-04	265	206	11	PS01186
Domain	EGF	GAS6 CNTNAP3 ADAM8 FBLN2 NRXN2 STAB2 LAMA2 EYS MEGF8 NAGPA	2.91e-04	235	206	10	SM00181
Domain	EGF_3	GAS6 CNTNAP3 ADAM8 FBLN2 NRXN2 C6 STAB2 EYS MEGF8 NAGPA	2.91e-04	235	206	10	PS50026
Domain	NCD3G	TAS1R3 CASR GPRC6A	3.49e-04	13	206	3	PF07562
Domain	GPCR_3_9-Cys_dom	TAS1R3 CASR GPRC6A	3.49e-04	13	206	3	IPR011500
Domain	Lipase_GDSL_2	PAFAH1B2 PAFAH1B3	3.61e-04	3	206	2	PF13472
Domain	ZO	TJP1 TJP3	3.61e-04	3	206	2	IPR005417
Domain	DUF2075	SLFN13 SLFN11	3.61e-04	3	206	2	PF09848
Domain	DUF2075	SLFN13 SLFN11	3.61e-04	3	206	2	IPR018647
Domain	-	APBB3 PLEKHM1 GRK2 GRK3 DNM1 FERMT2 DNM2 PRKD2 IQSEC3 ARHGAP23 PREX2 PLCD3 DNM3	4.19e-04	391	206	13	2.30.29.30
Domain	G_DYNAMIN_dom	DNM1 DNM2 DNM3	4.40e-04	14	206	3	IPR030381
Domain	GPCR_3_CS	TAS1R3 CASR GPRC6A	4.40e-04	14	206	3	IPR017979
Domain	G_DYNAMIN_2	DNM1 DNM2 DNM3	4.40e-04	14	206	3	PS51718
Domain	Dynamin_GTPase	DNM1 DNM2 DNM3	5.46e-04	15	206	3	IPR001401
Domain	Dynamin_SF	DNM1 DNM2 DNM3	5.46e-04	15	206	3	IPR022812
Domain	Dynamin_N	DNM1 DNM2 DNM3	5.46e-04	15	206	3	PF00350
Domain	Cadherin_2	PCDHGA9 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA1	7.51e-04	65	206	5	PF08266
Domain	Cadherin_N	PCDHGA9 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA1	7.51e-04	65	206	5	IPR013164
Domain	Lipase_GDSL	PAFAH1B2 PAFAH1B3	1.18e-03	5	206	2	PF00657
Domain	GDSL	PAFAH1B2 PAFAH1B3	1.18e-03	5	206	2	IPR001087
Domain	LIPASE_GDSL_SER	PAFAH1B2 PAFAH1B3	1.18e-03	5	206	2	PS01098
Domain	MFS	SLCO4A1 SLC22A20P MFSD9 MFSD12 SLC37A4 SLC22A31	1.26e-03	108	206	6	PS50850
Domain	GPCR_3	TAS1R3 CASR GPRC6A	1.52e-03	21	206	3	IPR000337
Domain	7tm_3	TAS1R3 CASR GPRC6A	1.74e-03	22	206	3	PF00003
Domain	G_PROTEIN_RECEP_F3_2	TAS1R3 CASR GPRC6A	1.74e-03	22	206	3	PS00980
Domain	G_PROTEIN_RECEP_F3_3	TAS1R3 CASR GPRC6A	1.74e-03	22	206	3	PS00981
Domain	G_PROTEIN_RECEP_F3_1	TAS1R3 CASR GPRC6A	1.74e-03	22	206	3	PS00979
Domain	G_PROTEIN_RECEP_F3_4	TAS1R3 CASR GPRC6A	1.74e-03	22	206	3	PS50259
Domain	GPCR_3_C	TAS1R3 CASR GPRC6A	1.74e-03	22	206	3	IPR017978
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	GAS6 PLEKHM1 MSI2 AFMID KIDINS220 GRK3 AIG1 PPIE NLGN2 SAMM50 XYLB ALG12 MOCOS ADSS1 ENOSF1 RHBDD1 PPFIBP2 SMURF1 H6PD COL18A1 TJP1 LPP ANKRD17 MACF1 TANC1 EIF2AK4 CSMD1 PARD3	1.08e-07	1489	210	28	28611215
Pubmed	Dynamin: characteristics, mechanism of action and function.	DNM1 DNM2 DNM3	2.17e-07	3	210	3	12511974
Pubmed	Disruption of the coxsackievirus and adenovirus receptor-homodimeric interaction triggers lipid microdomain- and dynamin-dependent endocytosis and lysosomal targeting.	DNM1 DNM2 DNM3	2.17e-07	3	210	3	24273169
Pubmed	Dynamin and endocytosis.	DNM1 DNM2 DNM3	2.17e-07	3	210	3	12383797
Pubmed	Developmental expression of the dynamin family of mechanoenzymes in the mouse epididymis.	DNM1 DNM2 DNM3	2.17e-07	3	210	3	28395327
Pubmed	Dynamin at the actin-membrane interface.	DNM1 DNM2 DNM3	2.17e-07	3	210	3	12517701
Pubmed	Dynamin triple knockout cells reveal off target effects of commonly used dynamin inhibitors.	DNM1 DNM2 DNM3	2.17e-07	3	210	3	24046449
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	CENPB GAS6 HLCS TUFM C2CD5 FCSK USP7 XYLB ILVBL PRKD2 ARHGAP23 PRSS56 GAS7 JPH1 SART1 TAF6L ANKRD17 MACF1 TANC1 SLFN11 USP54 CSMD1 PARD3	3.38e-07	1116	210	23	31753913
Pubmed	Chronic lithium treatment elicits its antimanic effects via BDNF-TrkB dependent synaptic downscaling.	BDNF DNM1 DNM3	8.64e-07	4	210	3	28621662
Pubmed	Overlapping role of dynamin isoforms in synaptic vesicle endocytosis.	DNM1 DNM2 DNM3	8.64e-07	4	210	3	21689597
Pubmed	Trans-infection but not infection from within endosomal compartments after cell-to-cell HIV-1 transfer to CD4+ T cells.	DNM1 DNM2 DNM3	8.64e-07	4	210	3	22846998
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	APBB3 RAP1GAP2 SLCO4A1 ITGA5 LYST PLEKHM1 NUAK1 RBM19 SLC35A2 USP7 NLGN2 SEMA6C PRKD2 FLNC B4GALNT4 MFSD12 PLCD3 MEGF8 CSPG4 PDCD11 TANC1 TJP3	1.09e-06	1105	210	22	35748872
Pubmed	Proteomic and yeast 2-hybrid screens to identify PTEN binding partners.	ATP5PB ACADVL PTGFRN TUFM USP7 PREX2 COL18A1 SCCPDH TJP1 PDCD11	1.31e-06	226	210	10	37839992
Pubmed	Candidate gene and locus analysis of myopia.	BDNF FGF2 COL18A1	2.15e-06	5	210	3	17653045
Pubmed	Growth factor-dependent phosphorylation of the actin-binding protein cortactin is mediated by the cytoplasmic tyrosine kinase FER.	DNM1 DNM2 DNM3	2.15e-06	5	210	3	9722593
Pubmed	Perinatal lethality and endothelial cell abnormalities in several vessel compartments of fibulin-1-deficient mice.	FBLN2 LAMA2 COL18A1 TJP1	2.22e-06	16	210	4	11564885
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	ATP5PB ACADVL LYST HNRNPD TUFM PHEX CLCN5 SACS PKHD1 CC2D2A HNRNPDL FLNC PCDHGA9 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA1 DUOX2 PCF11 SART1 SCCPDH TJP1 CSPG4 MACF1 EIF2AK4	2.36e-06	1442	210	25	35575683
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	SLCO4A1 GMIP TUFM SLC25A32 DNM1 ILVBL DNM2 MOCOS ARHGAP23 MFSD12 PLCD3 AIFM2 ARMC5 ANKRD17 TANC1 EIF2AK4	2.48e-06	650	210	16	38777146
Pubmed	Dynamin 1- and 3-Mediated Endocytosis Is Essential for the Development of a Large Central Synapse In Vivo.	DNM1 DNM2 DNM3	4.28e-06	6	210	3	27251629
Pubmed	Molecular components required for resting and stimulated endocytosis of botulinum neurotoxins by glutamatergic and peptidergic neurons.	DNM1 DNM2 DNM3	4.28e-06	6	210	3	23640057
Pubmed	A clathrin-dynamin-dependent endocytic pathway for the uptake of HIV-1 by direct T cell-T cell transmission.	DNM1 DNM2 DNM3	4.28e-06	6	210	3	18602423
Pubmed	Inferring nonneutral evolution from human-chimp-mouse orthologous gene trios.	H6PD EIF2AK4 CSMD1 PARD3	4.66e-06	19	210	4	14671302
Pubmed	A novel dynamin-associating molecule, formin-binding protein 17, induces tubular membrane invaginations and participates in endocytosis.	DNM1 DNM2 DNM3	7.46e-06	7	210	3	15252009
Pubmed	Large-scale concatenation cDNA sequencing.	WSB2 EXT1 DNM1 SEMA6C PLXDC1 SMURF1 MFSD9 NLRP1 TJP1 AIFM1 HECTD2 NUP133 CHRD NAGPA	1.05e-05	568	210	14	9110174
Pubmed	A "double adaptor" method for improved shotgun library construction.	WSB2 EXT1 DNM1 SEMA6C PLXDC1 SMURF1 MFSD9 NLRP1 TJP1 AIFM1 HECTD2 NUP133 CHRD NAGPA	1.18e-05	574	210	14	8619474
Pubmed	Functional interaction of Parkinson's disease-associated LRRK2 with members of the dynamin GTPase superfamily.	DNM1 DNM2 DNM3	1.19e-05	8	210	3	24282027
Pubmed	Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture.	BDNF MTMR11 ADAMTS17 RFT1 LINC02875 H6PD DNM3	1.42e-05	129	210	7	23563607
Pubmed	Major histocompatibility complex class-II molecules promote targeting of human immunodeficiency virus type 1 virions in late endosomes by enhancing internalization of nascent particles from the plasma membrane.	DNM1 DNM2 DNM3	1.77e-05	9	210	3	23170932
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	ATP5PB HNRNPD TUFM SEPTIN8 KIDINS220 GRK2 NRXN2 SACS USP7 SAMM50 DNM1 FERMT2 DNM2 FLNC IQSEC3 ARHGAP23 RTCB SMURF1 TJP1 PAFAH1B2 MACF1 TANC1 USP54	2.06e-05	1431	210	23	37142655
Pubmed	Protein partners of dynamin-1 in the retina.	DNM1 DNM2 DNM3	2.52e-05	10	210	3	23746204
Pubmed	The repertoire of olfactory C family G protein-coupled receptors in zebrafish: candidate chemosensory receptors for amino acids.	TAS1R3 CASR GPRC6A	2.52e-05	10	210	3	17156446
Pubmed	Expression and localisation of dynamin and syntaxin during neural development and neuromuscular synapse formation.	DNM1 DNM2 DNM3	2.52e-05	10	210	3	10398046
Pubmed	Rhomboid domain containing 1 promotes colorectal cancer growth through activation of the EGFR signalling pathway.	TUFM RHBDD1 MACF1	2.52e-05	10	210	3	26300397
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	HNRNPD TUFM RBM19 USP7 SAMM50 FERMT2 PNP HNRNPDL FLNC MRPS28 ARHGAP23 RTCB ABHD14B PLCD3 SART1 AIFM1 NUP133 PDCD11 ANKRD17 MACF1 TANC1 PARD3	2.64e-05	1353	210	22	29467282
Pubmed	Integrin repertoire on myogenic cells changes during the course of primary myogenesis in the mouse.	ITGA5 ITGA7 LAMA2	3.46e-05	11	210	3	15739233
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	KIDINS220 RBM33 TJP1 LPP NUP133 MACF1 TANC1 USP54 PARD3	3.46e-05	263	210	9	34702444
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	RBM12B HNRNPD TUFM KIDINS220 NRXN2 SACS MAMDC2 USP7 DNM1 FLNC MRPS28 RTCB SMURF1 TRIM71 PCF11 SART1 TJP1 DNM3 MACF1	3.47e-05	1082	210	19	38697112
Pubmed	The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin.	ATP5PB ACADVL HNRNPD KIDINS220 SACS USP7 FGF2 FERMT2 SART1 TAF6L PAFAH1B3	3.55e-05	400	210	11	35013556
Pubmed	The beta and gamma subunits of the human platelet-activating factor acetyl hydrolase isoform Ib (PAFAH1B2 and PAFAH1B3) map to chromosome 11q23 and 19q13.1, respectively.	PAFAH1B2 PAFAH1B3	3.63e-05	2	210	2	9693049
Pubmed	Endostatin competes with bFGF for binding to heparin-like glycosaminoglycans.	FGF2 COL18A1	3.63e-05	2	210	2	15985216
Pubmed	Differential appearance of dynamin in constitutive and regulated exo-endocytosis: a single-cell multiplex RT-PCR study.	DNM1 DNM2	3.63e-05	2	210	2	16028072
Pubmed	Dynamin regulates L cell secretion in human gut.	DNM1 DNM2	3.63e-05	2	210	2	34274446
Pubmed	Apoptosis-inducing Factor (AIF) and Its Family Member Protein, AMID, Are Rotenone-sensitive NADH:Ubiquinone Oxidoreductases (NDH-2).	AIFM2 AIFM1	3.63e-05	2	210	2	26063804
Pubmed	An intramolecular signaling element that modulates dynamin function in vitro and in vivo.	DNM1 DNM2	3.63e-05	2	210	2	19515832
Pubmed	Cloning of GRK2 cDNA from S49 murine lymphoma cells.	GRK2 GRK3	3.63e-05	2	210	2	8638670
Pubmed	Intracellular erythrocyte platelet-activating factor acetylhydrolase I inactivates aspirin in blood.	PAFAH1B2 PAFAH1B3	3.63e-05	2	210	2	21844189
Pubmed	Dissecting the roles of GRK2 and GRK3 in μ-opioid receptor internalization and β-arrestin2 recruitment using CRISPR/Cas9-edited HEK293 cells.	GRK2 GRK3	3.63e-05	2	210	2	33060647
Pubmed	Dynamin regulates specific membrane fusion events necessary for acrosomal exocytosis in mouse spermatozoa.	DNM1 DNM2	3.63e-05	2	210	2	22977254
Pubmed	FBXW10 promotes hepatocarcinogenesis in male patients and mice.	FBXW10B FBXW10	3.63e-05	2	210	2	31400758
Pubmed	Auto- and cross-regulation of the hnRNPs D and DL.	HNRNPD HNRNPDL	3.63e-05	2	210	2	29263134
Pubmed	Elevated FBXW10 drives hepatocellular carcinoma tumorigenesis via AR-VRK2 phosphorylation-dependent GAPDH ubiquitination in male transgenic mice.	FBXW10B FBXW10	3.63e-05	2	210	2	37450367
Pubmed	Dynamin at actin tails.	DNM1 DNM2	3.63e-05	2	210	2	11782545
Pubmed	Activity-Based Protein Profiling of Oncogene-Driven Changes in Metabolism Reveals Broad Dysregulation of PAFAH1B2 and 1B3 in Cancer.	PAFAH1B2 PAFAH1B3	3.63e-05	2	210	2	25945974
Pubmed	Dynamin 2-dependent endocytosis is essential for mouse oocyte development and fertility.	DNM1 DNM2	3.63e-05	2	210	2	32065700
Pubmed	Smurf1 inhibits integrin activation by controlling Kindlin-2 ubiquitination and degradation.	FERMT2 SMURF1	3.63e-05	2	210	2	28408404
Pubmed	Deubiquitylation and stabilization of ARMC5 by ubiquitin-specific processing protease 7 (USP7) are critical for RCC proliferation.	USP7 ARMC5	3.63e-05	2	210	2	33544460
Pubmed	Expression of a disintegrin and metalloprotease 8 and endostatin in human osteosarcoma: implication in tumor progression and prognosis.	ADAM8 COL18A1	3.63e-05	2	210	2	25481287
Pubmed	Differential curvature sensing and generating activities of dynamin isoforms provide opportunities for tissue-specific regulation.	DNM1 DNM2	3.63e-05	2	210	2	21670293
Pubmed	A view of response and resistance to atomoxetine treatment in children with ADHD: effects of CYP2C19 polymorphisms and BDNF levels.	CYP2C19 BDNF	3.63e-05	2	210	2	35486119
Pubmed	Dynamin is primed at endocytic sites for ultrafast endocytosis.	DNM1 DNM3	3.63e-05	2	210	2	35809574
Pubmed	A dynamin 1-, dynamin 3- and clathrin-independent pathway of synaptic vesicle recycling mediated by bulk endocytosis.	DNM1 DNM3	3.63e-05	2	210	2	24963135
Pubmed	Altered airway and cardiac responses in mice lacking G protein-coupled receptor kinase 3.	GRK2 GRK3	3.63e-05	2	210	2	10198406
Pubmed	G-protein coupled receptor kinase 2 and 3 expression in human detrusor cultured smooth muscle cells.	GRK2 GRK3	3.63e-05	2	210	2	11762794
Pubmed	Expression and distribution of ZO-3, a tight junction MAGUK protein, in mouse tissues.	TJP1 TJP3	3.63e-05	2	210	2	14622136
Pubmed	Crystal structure of the dynamin tetramer.	DNM1 DNM3	3.63e-05	2	210	2	26302298
Pubmed	Enlarged infarct volume and loss of BDNF mRNA induction following brain ischemia in mice lacking FGF-2.	BDNF FGF2	3.63e-05	2	210	2	15380477
Pubmed	Classical dynamin DNM1 and DNM3 genes attain maximum expression in the normal human central nervous system.	DNM1 DNM3	3.63e-05	2	210	2	24673776
Pubmed	G protein--coupled receptor kinases.	GRK2 GRK3	3.63e-05	2	210	2	8035170
Pubmed	Transgenic overexpression of the α7 integrin reduces muscle pathology and improves viability in the dy(W) mouse model of merosin-deficient congenital muscular dystrophy type 1A.	ITGA7 LAMA2	3.63e-05	2	210	2	21652631
Pubmed	Chimeric molecules between keratinocyte growth factor and basic fibroblast growth factor define domains that confer receptor binding specificities.	FGF2 FGFR4	3.63e-05	2	210	2	8530375
Pubmed	Dynamin GTPase regulation is altered by PH domain mutations found in centronuclear myopathy patients.	DNM1 DNM3	3.63e-05	2	210	2	20700106
Pubmed	The Structural and Functional Integrity of Rod Photoreceptor Ribbon Synapses Depends on Redundant Actions of Dynamins 1 and 3.	DNM1 DNM3	3.63e-05	2	210	2	38641407
Pubmed	Differential tissue distribution of the beta- and gamma-subunits of human cytosolic platelet-activating factor acetylhydrolase (isoform I).	PAFAH1B2 PAFAH1B3	3.63e-05	2	210	2	9144386
Pubmed	Dynamin-mediated lipid acquisition is essential for Chlamydia trachomatis development.	DNM1 DNM2	3.63e-05	2	210	2	25116793
Pubmed	A developmental stage- and Kidins220-dependent switch in astrocyte responsiveness to brain-derived neurotrophic factor.	BDNF KIDINS220	3.63e-05	2	210	2	34279618
Pubmed	Mouse Slfn8 and Slfn9 genes complement human cells lacking SLFN11 during the replication stress response.	SLFN13 SLFN11	3.63e-05	2	210	2	37833372
Pubmed	Linker proteins restore basement membrane and correct LAMA2-related muscular dystrophy in mice.	PRSS12 LAMA2	3.63e-05	2	210	2	28659438
Pubmed	Interaction of endostatin with integrins implicated in angiogenesis.	ITGA5 COL18A1	3.63e-05	2	210	2	11158588
Pubmed	Reduced release probability prevents vesicle depletion and transmission failure at dynamin mutant synapses.	DNM1 DNM3	3.63e-05	2	210	2	22308498
Pubmed	Deletion of integrin α7 subunit does not aggravate the phenotype of laminin α2 chain-deficient mice.	ITGA7 LAMA2	3.63e-05	2	210	2	26355035
Pubmed	Par3 and ZO-1 Membrane Clustering is an Indicator of Poor Prognosis in Lung Squamous Cell Carcinoma.	TJP1 PARD3	3.63e-05	2	210	2	34216486
Pubmed	Atypical, milder presentation in a child with CC2D2A and KIDINS220 variants.	KIDINS220 CC2D2A	3.63e-05	2	210	2	31577543
Pubmed	Structure of Schlafen13 reveals a new class of tRNA/rRNA- targeting RNase engaged in translational control.	SLFN13 SLFN11	3.63e-05	2	210	2	29563550
Pubmed	Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation.	ABCA13 KIDINS220 PKHD1 DNM1 TAF6L AIFM1 ANKRD17 EIF2AK4	4.18e-05	208	210	8	33230847
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	GAS6 LYST C2CD5 MSI2 NUAK1 USP7 FGF2 FGFR4 DNM2 PRKD2 RHBDD1 ARHGAP23 COL5A3 AIFM1 NUP133 DNM3 EIF2AK4	4.26e-05	910	210	17	36736316
Pubmed	Nell1-deficient mice have reduced expression of extracellular matrix proteins causing cranial and vertebral defects.	BDNF HOXD13 FGFR4 ALPP COL5A3 COL18A1 CSPG4 CHRD	4.47e-05	210	210	8	16537572
Pubmed	α-catenin interaction with YAP/FoxM1/TEAD-induced CEP55 supports liver cancer cell migration.	FERMT2 TJP1 LPP PARD3	5.84e-05	35	210	4	37381005
Pubmed	Comparative DNA sequence analysis of mouse and human protocadherin gene clusters.	PCDHGA9 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA1	5.86e-05	68	210	5	11230163
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	SLCO4A1 WSB2 EXT1 USP19 C2CD5 NUAK1 CLVS2 SLC35A2 AIG1 VSIG10L USP7 ALG12 SMURF1 PREX2 TAF6L AIFM1 ARMC5 PAFAH1B2 ANKRD17 EIF2AK4 SLFN11	5.98e-05	1327	210	21	32694731
Pubmed	Neural deletion of Tgfbr2 impairs angiogenesis through an altered secretome.	FGF2 COL18A1 TJP1 CSPG4	7.30e-05	37	210	4	24990151
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	ACADVL TUFM DNM2 FLNC RTCB SART1 TJP1 PAFAH1B2 LPP MACF1	7.41e-05	360	210	10	33111431
Pubmed	The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices.	ITIH1 FBLN2 ADAMTS17 LAMA2 COL5A3 COL18A1 CSPG4	7.41e-05	167	210	7	22159717
Pubmed	Plk2 attachment to NSF induces homeostatic removal of GluA2 during chronic overexcitation.	DNM1 DNM2 DNM3	7.52e-05	14	210	3	20802490
Pubmed	A striking organization of a large family of human neural cadherin-like cell adhesion genes.	PCDHGA9 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA1	7.71e-05	72	210	5	10380929
Pubmed	Cadherin superfamily genes: functions, genomic organization, and neurologic diversity.	PCDHGA9 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA1	8.79e-05	74	210	5	10817752
Pubmed	Maturation of postnatally generated olfactory bulb granule cells depends on functional γ-protocadherin expression.	PCDHGA9 PCDHGA6 PCDHGA3	9.36e-05	15	210	3	23515096
Pubmed	Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members.	PCDHGA9 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA1	1.06e-04	77	210	5	10835267
Pubmed	Extracellular Ca2+ is a danger signal activating the NLRP3 inflammasome through G protein-coupled calcium sensing receptors.	CASR GPRC6A	1.08e-04	3	210	2	23271661
Pubmed	Compound deletion of Fgfr3 and Fgfr4 partially rescues the Hyp mouse phenotype.	PHEX FGFR4	1.08e-04	3	210	2	21139072
Pubmed	Effects of the neurotrophic factors BDNF, NT-3, and FGF2 on dissociated neurons of the cochlear nucleus.	BDNF FGF2	1.08e-04	3	210	2	24978398
Interaction	DNASE1L1 interactions	CNTNAP3 SEC11C ITGA7 BDNF USP7 NLGN2 FGFR4 MEGF8 CSPG4 CHRD	4.00e-07	120	204	10	int:DNASE1L1
Interaction	C1orf54 interactions	GAS6 CNTNAP3 EXT1 ITGA7 BDNF ADAMTS17 FGFR4 B4GALNT4 COL18A1 CHRD	8.07e-06	167	204	10	int:C1orf54
Interaction	LY86 interactions	GAS6 CNTNAP3 ITGA5 ITGA7 PTGFRN BDNF FGFR4 PRKD2 PRSS12 CSPG4 CHRD	1.38e-05	217	204	11	int:LY86
Interaction	TRGV3 interactions	CNTNAP3 ITGA7 FGFR4 MEGF8 CSPG4 CHRD	1.92e-05	55	204	6	int:TRGV3
Interaction	ST8SIA4 interactions	CNTNAP3 ITGA7 PTGFRN TUFM NLGN2 PRKD2 TMBIM6	2.30e-05	84	204	7	int:ST8SIA4
Interaction	IL5RA interactions	CNTNAP3 ITGA5 ITGA7 FGFR4 COL18A1 MEGF8 CSPG4 CHRD	3.88e-05	124	204	8	int:IL5RA
Interaction	PDGFRA interactions	CNTNAP3 EXT1 ITGA7 BDNF KIDINS220 NLGN2 FGFR4 DNM2 PRSS12 SMURF1 H6PD JPH1 COL18A1 CHRD	4.03e-05	385	204	14	int:PDGFRA
Cytoband	5q31	APBB3 SEPTIN8 PCDHGA9 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA1	1.09e-06	115	210	7	5q31
Cytoband	11q13.1	GRK2 SLC22A20P SART1 SLC25A45	2.05e-04	63	210	4	11q13.1
Cytoband	Xp11.23-p11.22	CLCN5 SLC35A2	4.31e-04	7	210	2	Xp11.23-p11.22
Cytoband	Ensembl 112 genes in cytogenetic band chr5q31	APBB3 SEPTIN8 PCDHGA9 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA1	4.77e-04	298	210	7	chr5q31
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	PLEKHM1 GRK2 GRK3 DNM1 FERMT2 DNM2 PRKD2 ARHGAP23 DNM3	3.67e-05	206	142	9	682
GeneFamily	Calcium sensing receptors	CASR GPRC6A	6.13e-05	2	142	2	279
GeneFamily	Clustered protocadherins	PCDHGA9 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA1	1.46e-04	64	142	5	20
GeneFamily	Schlafen family	SLFN13 SLFN11	1.25e-03	7	142	2	1110
GeneFamily	PDZ domain containing	ARHGAP23 HTRA4 PREX2 TJP1 PARD3 TJP3	1.28e-03	152	142	6	1220
GeneFamily	RNA binding motif containing	RBM12B HNRNPD MSI2 RBM19 PPIE HNRNPDL RBM33	1.48e-03	213	142	7	725
Coexpression	ZHONG_PFC_C3_ASTROCYTE	GRK3 NRXN2 CLVS2 USP7 DNM1 SEMA6C B4GALNT4 RBM33 CYP27C1 GAS7 MAMDC4 TAF6L COL18A1 DNM3	3.25e-06	389	209	14	M39102
Coexpression	HE_LIM_SUN_FETAL_LUNG_C0_PERICYTE	GAS6 GRK3 PLXDC1 PPFIBP2 COL5A3 COL18A1 CSPG4 CHRD TANC1 MTSS2	4.03e-06	195	209	10	M45684
Coexpression	GSE13411_IGM_VS_SWITCHED_MEMORY_BCELL_UP	CYP2C19 NUAK1 PCDHGA9 PPFIBP2 COL5A3 OR10C1 TMBIM6 EDA COL18A1	2.62e-05	193	209	9	M3247
Coexpression	NABA_MATRISOME	GAS6 ADAM8 ITIH1 BDNF SERPINA4 FBLN2 ADAMTS17 FGF2 ADAMTSL4 SEMA6C PLXDC1 PRSS12 LAMA2 COL5A3 HTRA4 EDA COL18A1 EYS MEGF8 CSPG4 CHRD CTSS	2.63e-05	1026	209	22	M5889
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	VGLL3 EXT1 PHEX NUAK1 MAMDC2 FGFR4 LAMA2 PREX2 MACF1 PARD3	2.94e-08	193	210	10	b3ad5ff480d99217f36cc7471e5a96a519ddb409
ToppCell	PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	VGLL3 PHEX NUAK1 MAMDC2 ADAMTS17 FGFR4 PCDHGA9 H6PD PREX2 MACF1	3.24e-08	195	210	10	3a0cad69cfc150a27a0666f612f5294c817197d7
ToppCell	PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	VGLL3 PHEX NUAK1 MAMDC2 ADAMTS17 FGFR4 PCDHGA9 H6PD PREX2 MACF1	3.24e-08	195	210	10	2b8ee7990267bb52b7e6ae03f509ffebf8908122
ToppCell	droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RIPPLY3 SLCO4A1 FBLN2 NUAK1 SACS NLGN2 PREX2 CSPG4 DNM3	1.22e-07	170	210	9	8fe32dcf924d5f6665f7febbc9647d96b1e96f06
ToppCell	droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RIPPLY3 SLCO4A1 FBLN2 NUAK1 SACS NLGN2 PREX2 CSPG4 DNM3	1.22e-07	170	210	9	3232db50b1a40f861e981a1b9c9073b81af9f832
ToppCell	droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RIPPLY3 SLCO4A1 FBLN2 NUAK1 SACS NLGN2 PREX2 CSPG4 DNM3	1.22e-07	170	210	9	50c6c571591aa4b218caefe5778c570c809f567e
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GAS6 GRK3 CLVS2 PLXDC1 PPFIBP2 LAMA2 COL5A3 COL18A1 CSPG4	2.39e-07	184	210	9	102b6f621a5b551e622f97b12d787c080b052a72
ToppCell	10x3'2.3-week_12-13-Mesenchymal_myocytic-stroma-muscle\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	VGLL3 FGFR4 FLNC ARHGAP23 PCDHGA3 COL5A3 JPH1 TANC1 MTSS2	2.50e-07	185	210	9	0094f9baddb20214d2a2c166f1637d1a9cf1169a
ToppCell	PND14-Mesenchymal-Mesenchymal_structural\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PHEX NUAK1 MAMDC2 ADAMTS17 FGFR4 PCDHGA9 H6PD PREX2 MACF1	3.42e-07	192	210	9	25492568f9cbe097b7bb1db50d8b817c80ea87d7
ToppCell	PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PHEX NUAK1 MAMDC2 ADAMTS17 FGFR4 PCDHGA9 H6PD PREX2 MACF1	3.42e-07	192	210	9	de9c1536d5aee86f9c62acbc54ca8fa581c00f17
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	VGLL3 PHEX NUAK1 MAMDC2 ADAMTS17 FGFR4 LAMA2 PREX2 MACF1	3.58e-07	193	210	9	99525545552b371c86b18b6ea6f4897dc6e9a9ec
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GAS6 FGFR4 FERMT2 LAMA2 COL5A3 PREX2 COL18A1 CSPG4 CHRD	3.73e-07	194	210	9	8f19e553f18c313c2a2ff9453884b9484b255d71
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GAS6 FGFR4 FERMT2 LAMA2 COL5A3 PREX2 COL18A1 CSPG4 CHRD	3.73e-07	194	210	9	67fbb81b7d20cb63be27b2a2beea5b5689f8e08c
ToppCell	proximal-3-mesenchymal-Pericyte\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	GAS6 FERMT2 PLXDC1 LAMA2 COL5A3 PREX2 COL18A1 TJP1 CSPG4	4.82e-07	200	210	9	98cbd0f4994e645f70c0bc5ebc1c3a3b28c6b67f
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	GAS6 SEPTIN8 FERMT2 PLXDC1 PPFIBP2 LAMA2 COL5A3 COL18A1 CSPG4	4.82e-07	200	210	9	cf883ba5dbe6350b93142d625a52b25ff2a8bb63
ToppCell	proximal-mesenchymal-Pericyte\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	GAS6 FERMT2 PLXDC1 LAMA2 COL5A3 PREX2 COL18A1 TJP1 CSPG4	4.82e-07	200	210	9	03119a979bc912a98e6fc87addcbc25d8ecf2fb0
ToppCell	proximal-mesenchymal-Pericyte-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	GAS6 FERMT2 PLXDC1 LAMA2 COL5A3 PREX2 COL18A1 TJP1 CSPG4	4.82e-07	200	210	9	a81fde3d40b8efb3be535aeb2a44cfbdeb17bc8b
ToppCell	facs-Lung-EPCAM-3m-Myeloid-Nonclassical_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAP1GAP2 GRK2 GRK3 CLVS2 ADSS1 PRSS56 CTSS SLC25A45	8.71e-07	158	210	8	b0508a600994090c6aafd8d779437190a33ad821
ToppCell	facs-Lung-EPCAM-3m-Myeloid-non-classical_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAP1GAP2 GRK2 GRK3 CLVS2 ADSS1 PRSS56 CTSS SLC25A45	8.71e-07	158	210	8	a816cc095452308d06f87b77467e2a8c6361fd2a
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-10\|TCGA-Colorectal / Sample_Type by Project: Shred V9	VGLL3 GLT1D1 NUAK1 NALCN PCDHGA9 CHRD HHIPL1 SLFN11	2.22e-06	179	210	8	cc079ba015326dccde955c5eafa3e4a2e40de192
ToppCell	normal_Lung-Fibroblasts-Pericytes\|normal_Lung / Location, Cell class and cell subclass	GAS6 ITGA7 PLXDC1 LINC02875 COL5A3 COL18A1 CSPG4 CHRD	2.41e-06	181	210	8	f74941e49950027360d71ea3b205fc20c6929766
ToppCell	5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PCSK2 VGLL3 FBLN2 NRXN2 GAS7 COL5A3 COL18A1 CSMD1	2.41e-06	181	210	8	098dbb3e0ff531c9720a233123250c1e39a97d4c
ToppCell	COVID-19-Fibroblasts-Pericytes\|COVID-19 / group, cell type (main and fine annotations)	ITGA7 PLXDC1 COL5A3 PREX2 COL18A1 TJP1 CSPG4 PARD3	2.84e-06	185	210	8	4905adaeeffd353e089578e5ea614437dbe794e6
ToppCell	droplet-Lung-LUNG-30m-Mesenchymal-fibroblast_of_lung\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VGLL3 MAMDC2 FGFR4 FERMT2 LAMA2 H6PD PREX2 COL18A1	2.95e-06	186	210	8	1ed71b229f40a680071b14f5a7a19706e0fd14b1
ToppCell	droplet-Lung-LUNG-30m-Mesenchymal-Alveolar_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VGLL3 MAMDC2 FGFR4 FERMT2 LAMA2 H6PD PREX2 COL18A1	2.95e-06	186	210	8	ca5e9c6531cb5d199e27509bfab1d62e3937177e
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CLVS2 FGFR4 LAMA2 COL5A3 PREX2 COL18A1 CSPG4 CHRD	2.95e-06	186	210	8	888e85a025bd982d36c910db0f5a3385b1ca3b28
ToppCell	COPD-Stromal-Pericyte\|World / Disease state, Lineage and Cell class	FGFR4 FERMT2 COL5A3 COL18A1 TJP1 CHRD TANC1 PARD3	2.95e-06	186	210	8	8adfd2d1fda4e8aecc95192ea627bf7ed5214b8d
ToppCell	droplet-Lung-LUNG-30m-Mesenchymal\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VGLL3 MAMDC2 FERMT2 LAMA2 H6PD PREX2 COL18A1 CSPG4	3.07e-06	187	210	8	976b74d081b7fba8620768613cc26f9262cd7b16
ToppCell	Fetal_29-31_weeks-Mesenchymal-pericyte_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PLXDC1 PPFIBP2 COL5A3 PREX2 COL18A1 TJP1 CSPG4 TANC1	3.07e-06	187	210	8	a2bf958ea59c359a265bfa437d59315e1920cdd4
ToppCell	PND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	VGLL3 EXT1 PHEX NUAK1 ADAMTS17 PREX2 COL18A1 MACF1	3.46e-06	190	210	8	1196b8ea2c44c7c80f5ee589dd517e6a413f2077
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ITGA7 BDNF MAMDC2 ZBTB7C PLXDC1 OAZ2 COL18A1 CSPG4	3.60e-06	191	210	8	239c1e68eb1cbe3e137a99fbd6eeb8d64c919ffd
ToppCell	facs-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	VGLL3 NRXN2 MAMDC2 ADAMTS17 FGFR4 H6PD PREX2 MACF1	3.60e-06	191	210	8	6609d85fd2577633dcc067507304a6f9e5865ca3
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GAS6 FERMT2 LAMA2 COL5A3 PREX2 COL18A1 CSPG4 CHRD	3.60e-06	191	210	8	1626b23a57429f835fddc052e3c57f63a4e5b8bb
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	VGLL3 ITGA7 ITIH1 BDNF FERMT2 FLNC CSPG4 LPP	3.60e-06	191	210	8	2a107e9096eb58b81b3da61547904d85754f6b2f
ToppCell	facs-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	VGLL3 NRXN2 MAMDC2 ADAMTS17 FGFR4 H6PD PREX2 MACF1	3.60e-06	191	210	8	beb5bb42bd53bce01339da9110d374901548793c
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes-Fibromyocytes_L.2.3.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	VGLL3 ITGA7 ITIH1 BDNF FERMT2 FLNC CSPG4 LPP	3.60e-06	191	210	8	d35692c652977500a3c36aa26c347a072b71e441
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GAS6 FERMT2 LAMA2 COL5A3 PREX2 COL18A1 CSPG4 CHRD	3.60e-06	191	210	8	716dfa7fccbd62b5f574792e68a26dc6c45511dc
ToppCell	droplet-Lung-nan-18m-Mesenchymal\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VGLL3 GAS6 MAMDC2 FGFR4 FERMT2 LAMA2 H6PD PREX2	3.74e-06	192	210	8	df56c3e3bb1aafc1126607f4426554c09c8c40cf
ToppCell	droplet-Lung-nan-18m-Mesenchymal-Alveolar_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VGLL3 GAS6 MAMDC2 FGFR4 FERMT2 H6PD PREX2 MACF1	3.74e-06	192	210	8	d22c1135867bcb9076435e2c6eb1cc1248990d0c
ToppCell	droplet-Lung-nan-18m-Mesenchymal-fibroblast_of_lung\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VGLL3 GAS6 MAMDC2 FGFR4 FERMT2 H6PD PREX2 MACF1	3.74e-06	192	210	8	c09966f4d63a739a56db4df7e0e0ee9ecacd21ad
ToppCell	3'-GW_trimst-1-LargeIntestine-Mesenchymal-Pericytes\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VGLL3 BDNF MOCOS PLXDC1 COL5A3 OAZ2 COL18A1 CSPG4	3.88e-06	193	210	8	47d189bac0ef4df2f5c6dd987e46aca85bd7e2af
ToppCell	3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GAS6 FERMT2 PLXDC1 COL5A3 PREX2 COL18A1 CSPG4 CHRD	3.88e-06	193	210	8	b2abe939027a69b60d83a28d4d4cc53ba1dee4c5
ToppCell	3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GAS6 FERMT2 PLXDC1 COL5A3 PREX2 COL18A1 CSPG4 CHRD	3.88e-06	193	210	8	d75f334fe3d9f39ef02a5de0f8202f7a761a8fc8
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	VGLL3 PHEX ADAMTS17 FGFR4 PCDHGA9 H6PD PREX2 MACF1	3.88e-06	193	210	8	8d05805295c5d3aa93aeb38be5fbefa81e1be1f0
ToppCell	3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GAS6 FERMT2 PLXDC1 COL5A3 PREX2 COL18A1 CSPG4 CHRD	3.88e-06	193	210	8	41ea268e7697101fe70d8ef1045f3a43b9311739
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	VGLL3 PHEX ADAMTS17 FGFR4 PCDHGA9 H6PD PREX2 MACF1	3.88e-06	193	210	8	1b2cc627b2aa002b442358bd1188d470e67ce7d9
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	VGLL3 PHEX NUAK1 MAMDC2 ADAMTS17 FGF2 FGFR4 LAMA2	4.03e-06	194	210	8	e93de9428c986b8943fc169258847c650cfab0e5
ToppCell	10x3'2.3-week_17-19-Mesenchymal_fibro-stroma-endosteal_fibroblast\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	FBLN2 MAMDC2 ADAMTS17 DNM1 ZBTB7C CYP27C1 CSPG4 HHIPL1	4.03e-06	194	210	8	69362e13158033de44f90f3773db6c0f27de8cb3
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GAS6 FERMT2 PLXDC1 COL5A3 PREX2 COL18A1 CSPG4 CHRD	4.03e-06	194	210	8	3cffb5c58f6d5bd254f39ee9c41b7e1e4da0ff75
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	VGLL3 PHEX ADAMTS17 FGFR4 PCDHGA9 H6PD PREX2 MACF1	4.19e-06	195	210	8	b616ee6f1d878935d293c8e0a8bbc5b4385301f0
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	VGLL3 PHEX NUAK1 ADAMTS17 FGFR4 PCDHGA9 PREX2 MACF1	4.19e-06	195	210	8	1c1135be421af98cd0077bec1ff2c4158d42aa21
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	VGLL3 PHEX NUAK1 ADAMTS17 FGFR4 PCDHGA9 PREX2 MACF1	4.19e-06	195	210	8	1f005ee1da66b539bd200aaa98f46edbbc7f12e4
ToppCell	PND07-Mesenchymal-Mesenchymal_structural\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	VGLL3 PHEX ADAMTS17 FGFR4 PCDHGA9 H6PD PREX2 MACF1	4.19e-06	195	210	8	2f9a274b26fc528a85f50933ec2f4db1dc9da0ca
ToppCell	Fibroblasts-DKK3+_Fibroblasts\|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	PTGFRN FBLN2 MAMDC2 DNM1 FLNC PLXDC1 LAMA2 GAS7	4.35e-06	196	210	8	24d64b67aa9b0e8215ad06f9101c1314b3483620
ToppCell	cellseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	GAS6 FERMT2 PLXDC1 LAMA2 COL5A3 COL18A1 CSPG4 CHRD	4.35e-06	196	210	8	8b5337ccf74de90e8b89a02ac00671af1de2cfff
ToppCell	cellseq-Mesenchymal-Myocytic-Myocytic_1\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	GAS6 FERMT2 PLXDC1 LAMA2 COL5A3 COL18A1 CSPG4 CHRD	4.35e-06	196	210	8	c373465e34e2dd581247962d59e0477aae877079
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ITGA7 BDNF PLXDC1 COL5A3 OAZ2 COL18A1 TJP1 CSPG4	4.35e-06	196	210	8	624f700daea48d9bad4cc554f4776bd809ae1e54
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	FBXW10B VGLL3 SLC22A20P PLXDC1 TM9SF1 LAMA2 COL18A1 TJP1	4.52e-06	197	210	8	2872a78b1be61aa1d50bc9a49294a21e922dc033
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GAS6 ITGA7 FERMT2 COL5A3 PREX2 COL18A1 CSPG4 CHRD	4.52e-06	197	210	8	01249bd485a3734de87ae6ed9c749597f39c6335
ToppCell	wk_20-22-Mesenchymal-Myofibro_&_SMC-Pericyte\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	FERMT2 LAMA2 COL5A3 COL18A1 TJP1 CSPG4 CHRD TANC1	4.52e-06	197	210	8	44cd1ece3633a31e8c9b667cd3cbc2749c06f478
ToppCell	10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma-muscle_stem_cell\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	VGLL3 ITGA7 PTGFRN CLCN5 FGFR4 FLNC LAMA2 EDA	4.69e-06	198	210	8	55e583321f60c95898d93cd0d2615c6692db52ec
ToppCell	Fibroblasts-DKK3+_Fibroblasts\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	PTGFRN FBLN2 MAMDC2 DNM1 FERMT2 FLNC PLXDC1 LAMA2	4.69e-06	198	210	8	4f4632f26a2043c5e4ab89031b4229b5dca1bd48
ToppCell	wk_15-18-Mesenchymal-Myofibro_&_SMC-Pericyte\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	GAS6 FERMT2 PLXDC1 COL5A3 TJP1 CSPG4 CHRD TANC1	4.69e-06	198	210	8	76d46950c11cb4708866db0da54ce00d5c0adab8
ToppCell	10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	VGLL3 ITGA7 PTGFRN CLCN5 FGFR4 FLNC LAMA2 EDA	4.87e-06	199	210	8	e19b296d583f8bad3b66ee998a8153634d6fe09e
ToppCell	10x3'2.3-week_17-19-Mesenchymal_myocytic\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	VGLL3 ITGA7 PTGFRN CLCN5 FGFR4 FLNC LAMA2 EDA	4.87e-06	199	210	8	801887db51ac5dc5b068808ff75e3a46643398e9
ToppCell	medial-mesenchymal-Pericyte-2\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	GAS6 FERMT2 PLXDC1 LAMA2 COL5A3 COL18A1 CSPG4 CHRD	5.05e-06	200	210	8	bbda454260016be92b539e220ecf7bcbbc6139e4
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	GAS6 FGFR4 LAMA2 COL5A3 PREX2 COL18A1 CSPG4 TANC1	5.05e-06	200	210	8	0c648941447c738caf62f2d71e296d6cca492c8b
ToppCell	medial-mesenchymal-Pericyte\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	GAS6 FERMT2 PLXDC1 LAMA2 COL5A3 COL18A1 CSPG4 CHRD	5.05e-06	200	210	8	f36d7cb6345daccebf76997f998e35d959b59452
ToppCell	Tracheal-10x3prime_v2-Stromal-Peri/Epineurial_-NAF_epineurial\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	ITGA7 AFMID FERMT2 ZBTB7C ARHGAP23 PLXDC1 PLCD3 ARMC5	5.05e-06	200	210	8	24e13b6d9d2d8b29df1f02544ea9c50084d9e75c
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	GAS6 FGFR4 LAMA2 COL5A3 PREX2 COL18A1 CSPG4 TANC1	5.05e-06	200	210	8	522a51a284d2992d519c4669e1a48c8ebcc08c80
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	GAS6 FGFR4 LAMA2 COL5A3 PREX2 COL18A1 CSPG4 TANC1	5.05e-06	200	210	8	94f1fa61aa82eb9f411b2b1cb759476939ab5db7
ToppCell	Biopsy_Control_(H.)-Mesenchymal-PLIN2+_Fibroblasts\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	VGLL3 ITGA7 FBLN2 DNM1 FLNC PCDHGA3 LAMA2 HHIPL1	5.05e-06	200	210	8	cdaf462b1db29dab61038eeab5ddd3eef3386763
ToppCell	distal-mesenchymal-Pericyte\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	GAS6 FERMT2 PLXDC1 LAMA2 COL5A3 COL18A1 CSPG4 CHRD	5.05e-06	200	210	8	fe31287cfb51d45643bdedbaa5efc03ed87263c6
ToppCell	medial-2-mesenchymal-Pericyte\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	GAS6 FERMT2 PLXDC1 LAMA2 COL5A3 COL18A1 CSPG4 CHRD	5.05e-06	200	210	8	9820fb4f6efcdfc6de937ef2302a98b48426baa3
ToppCell	Tracheal-10x3prime_v2-Stromal-Peri/Epineurial_\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	ITGA7 FERMT2 ZBTB7C ARHGAP23 PLXDC1 PLCD3 ARMC5 USP54	5.05e-06	200	210	8	f7c3a8f5ac156c05ad7335d6d142c154c7d86449
ToppCell	distal-mesenchymal-Pericyte-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	GAS6 FERMT2 PLXDC1 LAMA2 COL5A3 COL18A1 CSPG4 CHRD	5.05e-06	200	210	8	867935701fac71a3fe01578362da0676f959736c
ToppCell	facs-Trachea-3m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_trachea\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ADAM8 C6 ADSS1 NAPSA IDO2 MYO15A CTSS	5.59e-06	144	210	7	8bd042f12186f36bc5aabf6a0232270a448f4b58
ToppCell	390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5\|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)	RAP1GAP2 VSIG10L ARHGAP23 PRSS12 LINC02875 MEGF8 PARD3	8.32e-06	153	210	7	e7d20c88466ff81db613869cf7a6a4bb95fd6c2f
ToppCell	PND07-28-samps-Myeloid-Granulocyte\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	RAP1GAP2 LYST GRK3 ADSS1 NAPSA LACC1 SLC25A45	9.44e-06	156	210	7	5e1c5a7c9293b886920739cf766521df7f69726c
ToppCell	PND07-28-samps-Myeloid-Granulocyte-neutrophil__Lgals3-negative\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	RAP1GAP2 LYST GRK3 ADSS1 NAPSA LACC1 SLC25A45	9.44e-06	156	210	7	166f7b1220eaf8e1149dde260dd85a094855c54f
ToppCell	Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ITGA7 MAMDC2 NLGN2 FLNC COL5A3 HECTD2 CSPG4	1.07e-05	159	210	7	7cda111bb98f1241989e49d490bdf51a712ea589
ToppCell	356C-Myeloid-Macrophage-FABP4+_Macrophage_4\|356C / Donor, Lineage, Cell class and subclass (all cells)	MTMR11 CLCN5 PIP5KL1 CC2D2A MOCOS IQSEC3 ZBTB7C	1.21e-05	162	210	7	7d43d59531cbefe3ac94953b7faf7156b2a31441
ToppCell	E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Mature_Fibroblast_1\|E16.5-samps / Age Group, Lineage, Cell class and subclass	VGLL3 ADAMTS17 FGFR4 PCDHGA6 PREX2 LIPE MACF1	1.26e-05	163	210	7	f1ec2625b52664308968b01d8e0275e1e0751480
ToppCell	Adult-Mesenchymal-chondrocyte-D231\|Adult / Lineage, Cell type, age group and donor	MAMDC2 NLGN2 FGFR4 MRPS28 LAMA2 COL18A1 HHIPL1	1.31e-05	164	210	7	2ba57dce5f69a88f0d1e450b9780425e2d9ca7d4
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal-Pericytes-angiogenic_pericyte\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ITGA7 BDNF MAMDC2 PLXDC1 COL5A3 OAZ2 CSPG4	1.65e-05	170	210	7	d9ed257d0938442d0bb280e4c4b0c9b657511b46
ToppCell	Control-Fibroblasts-Pericytes\|Control / group, cell type (main and fine annotations)	ITGA7 PLXDC1 LAMA2 COL5A3 PREX2 COL18A1 CSPG4	1.71e-05	171	210	7	080003f698f867935c2bfc55d241d3650f45a0ab
ToppCell	droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-plasma_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GAS6 GRK3 C6 STAB2 PCDHGA1 HTRA4 CTSS	1.78e-05	172	210	7	7295bf3ae21a61dd6bcfa0dfb7a37d0f3e8f94ab
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Neuron\|GW19 / Sample Type, Dataset, Time_group, and Cell type.	NLGN2 PNP RHBDD1 PPFIBP2 EDA SART1 LIPE	1.99e-05	175	210	7	2812ac2ef41d245db544697fb6da1883361c96e8
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	VGLL3 NALCN MAMDC2 FGF2 LAMA2 LPP MACF1	1.99e-05	175	210	7	1799a7be623dc3bf53ba580a7c47d2619969d708
ToppCell	droplet-Fat-Bat-18m-Mesenchymal-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCSK2 GNB1L H6PD EDA CHRD CSMD1 TJP3	1.99e-05	175	210	7	b4f01e7782cdd107d0817ef601891fd3a382bc35
ToppCell	droplet-Fat-Bat-18m-Mesenchymal\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCSK2 GNB1L H6PD EDA CHRD CSMD1 TJP3	1.99e-05	175	210	7	7f7598d46d10bff1cbea42f950bdde1aaa16e9a4
ToppCell	droplet-Fat-Bat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCSK2 GNB1L H6PD EDA CHRD CSMD1 TJP3	1.99e-05	175	210	7	ef6f811d8e1839f405c3b41090ddf79be57a099f
ToppCell	droplet-Heart-4Chambers-21m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCSK2 PRSS12 PPFIBP2 GAS7 EDA COL18A1 CSMD1	2.22e-05	178	210	7	3e8aacb27ed1a3c3978e21dddddd0828f8000692
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_G2M\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GAS6 FBLN2 SACS FLNC ZBTB7C PLCD3 CHRD	2.30e-05	179	210	7	adf8b025032a03dbb58871a92025cd7efbeb22ff
ToppCell	droplet-Bladder-nan-24m-Epithelial-nan\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN2 NRXN2 SACS FGF2 COL5A3 EDA CSMD1	2.30e-05	179	210	7	dfd9d29281510d32f1a2e8336d2e58ef496cfd1d
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PHEX GRK3 NUAK1 MAMDC2 ADAMTS17 PRSS12 GAS7	2.38e-05	180	210	7	08ae0f5d95c45feba68ad99788f7af7ff4c979af
ToppCell	3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PCSK2 VGLL3 FBLN2 LAMA2 GAS7 COL5A3 COL18A1	2.38e-05	180	210	7	b294f9db1e2ff51c94cde64fae4c2b057c0030a1
ToppCell	facs-Marrow-Granulocytes-3m-Lymphocytic-mature_alpha-beta_T_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SACS PKHD1 GNB1L LAMA2 CD8A GZMM USP54	2.47e-05	181	210	7	41969fe4d94ee77b12ecde32170aaf0b13e49644
ToppCell	facs-Marrow-Granulocytes-3m-Lymphocytic-BM_CD8_+_CD4_T_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SACS PKHD1 GNB1L LAMA2 CD8A GZMM USP54	2.47e-05	181	210	7	3f50e61dc2a52d71a5801584617607e6246adcf2
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VGLL3 SEC11C FBLN2 NRXN2 GAS7 COL18A1 SCCPDH	2.56e-05	182	210	7	ecb5624c9074cc6449fad961df54c926c2681d54
Computational	Neighborhood of NCAM1	WSB2 USP19 C2CD5 KIDINS220 NUAK1 PAFAH1B2 ANKRD17 PHYHIPL	7.97e-05	127	119	8	GCM_NCAM1
Drug	Mephenytoin [50-12-4]; Down 200; 18.4uM; MCF7; HT_HG-U133A	GAS6 USP19 GRK3 CLCN5 USP7 ALG12 GNB1L SMURF1 GAS7 TNKS2 TJP3	2.00e-06	195	209	11	3580_DN
Drug	AC1L1KMJ	ITGA5 GRK2 GRK3 SACS TUBA4B DNM1 DNM2 ALPP PRKD2 LAMA2 GAS7 COL18A1 TJP1 DNM3 MACF1 MYO15A TJP3	2.10e-06	476	209	17	CID000030956
Disease	mental development measurement	PCDHGA9 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA1	7.31e-07	25	205	5	EFO_0008230
Disease	centronuclear myopathy 1 (implicated_via_orthology)	DNM1 DNM2 DNM3	3.27e-06	5	205	3	DOID:0111223 (implicated_via_orthology)
Disease	microcytic anemia (implicated_via_orthology)	DNM1 DNM2 DNM3	3.27e-06	5	205	3	DOID:11252 (implicated_via_orthology)
Disease	Charcot-Marie-Tooth disease dominant intermediate B (implicated_via_orthology)	DNM1 DNM2 DNM3	3.27e-06	5	205	3	DOID:0110197 (implicated_via_orthology)
Disease	childhood trauma measurement, alcohol consumption measurement	PCDHGA9 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA1 NLRP1	1.03e-05	71	205	6	EFO_0007878, EFO_0007979
Disease	Sarcosine measurement	PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA1	1.81e-05	23	205	4	EFO_0021668
Disease	Vitamin D-Resistant Rickets, X-Linked	PHEX CLCN5	4.80e-05	2	205	2	C3536984
Disease	Muscular dystrophy congenital, merosin negative	ITGA7 LAMA2	4.80e-05	2	205	2	C1263858
Disease	Hypophosphatemic Rickets, X-Linked Dominant	PHEX CLCN5	4.80e-05	2	205	2	C0733682
Disease	Rickets, X-Linked Hypophosphatemic	PHEX CLCN5	4.80e-05	2	205	2	C3540852
Disease	Hypophosphatemic Rickets, X-Linked Recessive	PHEX CLCN5	4.80e-05	2	205	2	C1845168
Disease	collagen disease (implicated_via_orthology)	DNM1 DNM2 DNM3	6.94e-05	12	205	3	DOID:854 (implicated_via_orthology)
Disease	developmental and epileptic encephalopathy (implicated_via_orthology)	DNM1 DNM2 DNM3	8.98e-05	13	205	3	DOID:0112202 (implicated_via_orthology)
Disease	Familial Hypophosphatemic Rickets	PHEX CLCN5	1.43e-04	3	205	2	C3536983
Disease	Astrocytosis	ITGA5 BDNF FGF2	2.09e-04	17	205	3	C3887640
Disease	Gliosis	ITGA5 BDNF FGF2	2.09e-04	17	205	3	C0017639
Disease	open-angle glaucoma	ITIH1 PKHD1 PCDHGA5 GNB1L GAS7 LPP ACOXL	3.95e-04	191	205	7	EFO_0004190
Disease	Hypophosphatemic rickets	PHEX CLCN5	4.74e-04	5	205	2	cv:C1704375
Disease	Hereditary hypophosphatemic rickets	PHEX CLCN5	4.74e-04	5	205	2	cv:CN296404
Disease	Rickets	PHEX CLCN5	4.74e-04	5	205	2	cv:C0035579
Disease	nighttime rest measurement	HLCS TANC1 CSMD1	6.01e-04	24	205	3	EFO_0007827
Disease	aspartate aminotransferase measurement	GAS6 ITIH1 PLEKHM1 BDNF SAMM50 FGFR4 MOCOS PNP PRKD2 MFSD12 ACMSD CSMD1 MYO15A CTSS ACOXL TJP3	6.18e-04	904	205	16	EFO_0004736
Disease	autism spectrum disorder (implicated_via_orthology)	CNTNAP3 EXT1 NRXN2 NLGN2 GPRASP2 MOCOS	6.99e-04	152	205	6	DOID:0060041 (implicated_via_orthology)
Disease	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1	DNM1 ARX	7.07e-04	6	205	2	C3463992
Disease	Congenital muscular dystrophy (disorder)	ITGA7 LAMA2	7.07e-04	6	205	2	C0699743
Disease	autosomal dominant limb-girdle muscular dystrophy type 3 (implicated_via_orthology)	HNRNPD HNRNPDL	7.07e-04	6	205	2	DOID:0110306 (implicated_via_orthology)
Disease	renal system measurement, uric acid measurement	NRXN2 PRKD2	7.07e-04	6	205	2	EFO_0004742, EFO_0004761
Disease	bipolar disorder, schizophrenia, schizoaffective disorder	ITIH1 CSMD1	7.07e-04	6	205	2	EFO_0005411, MONDO_0004985, MONDO_0005090
Disease	quinolinate measurement	IDO2 ACMSD	9.86e-04	7	205	2	EFO_0800175
Disease	Goiter	CLCN5 DUOX2	9.86e-04	7	205	2	C0018021
Disease	Angle Closure Glaucoma	FERMT2 PRSS56	9.86e-04	7	205	2	C0017605
Disease	intellectual disability (is_implicated_in)	CC2D2A PRSS12 CASR	1.17e-03	30	205	3	DOID:1059 (is_implicated_in)
Disease	corneal resistance factor	CFAP95 SEPTIN8 FBLN2 MAMDC2 ADAMTS17 XYLB DNM2 GAS7 MAMDC4 TJP1	1.30e-03	451	205	10	EFO_0010067
Disease	X-linked infantile spasms	DNM1 ARX	1.31e-03	8	205	2	C4552072
Disease	uridine measurement	NALCN PRKD2 CSMD1	1.41e-03	32	205	3	EFO_0010546
Disease	cardiomyopathy (implicated_via_orthology)	ITGA7 CASR JPH1 COL18A1	1.53e-03	71	205	4	DOID:0050700 (implicated_via_orthology)
Disease	retinal degeneration (implicated_via_orthology)	BDNF FSCN2 EYS	1.55e-03	33	205	3	DOID:8466 (implicated_via_orthology)
Disease	clopidogrel metabolite measurement	CYP2C19 USP7 SLFN13	1.55e-03	33	205	3	EFO_0007966
Disease	cognitive disorder (is_implicated_in)	BDNF FGF2	1.67e-03	9	205	2	DOID:1561 (is_implicated_in)
Disease	Spastic Paraplegia	LYST HACE1	1.67e-03	9	205	2	C0037772
Disease	BMI-adjusted waist circumference, physical activity measurement	ITIH1 MTMR11 FGFR4 LINC02875 DNM3	1.72e-03	123	205	5	EFO_0007789, EFO_0008002
Disease	emphysema	FBLN2 CSMD1 PARD3	1.84e-03	35	205	3	EFO_0000464
Disease	body surface area	SEC11C BDNF FBLN2 MTMR11 ADAMTS17 PKHD1 FGFR4 LINC02875 H6PD DNM3 MACF1 PARD3	1.91e-03	643	205	12	EFO_0022196
Disease	Cryptogenic Tonic-Clonic Epilepsy	BDNF FGF2	2.08e-03	10	205	2	C0751117
Disease	Epilepsy, Tonic-Clonic, Symptomatic	BDNF FGF2	2.08e-03	10	205	2	C0751119
Disease	Epilepsy, Tonic-Clonic, Familial	BDNF FGF2	2.08e-03	10	205	2	C0751118
Disease	Tonic-Clonic Epilepsy	BDNF FGF2	2.08e-03	10	205	2	C0014549
Disease	Congenital Disorders of Glycosylation	FCSK SLC35A2	2.08e-03	10	205	2	C0282577
Disease	macrophage colony stimulating factor measurement	PREX2 MTRR CSMD1	2.16e-03	37	205	3	EFO_0008217
Disease	visceral heterotaxy (implicated_via_orthology)	CC2D2A MEGF8 MTRR	2.16e-03	37	205	3	DOID:0050545 (implicated_via_orthology)
Disease	Congenital disorder of glycosylation	RFT1 ALG12 DPAGT1	2.33e-03	38	205	3	cv:C0282577
Disease	Retinal Detachment	COL18A1 AIFM1	2.54e-03	11	205	2	C0035305
Disease	Parkinsonism (is_implicated_in)	BDNF FGF2	2.54e-03	11	205	2	DOID:0080855 (is_implicated_in)
Disease	non-melanoma skin carcinoma	BRCA2 SART1 LPP PARD3 MYO15A CTSS SLC22A31	2.63e-03	265	205	7	EFO_0009260
Disease	response to simvastatin, myopathy	ABCA13 CLVS2 CSPG4	2.90e-03	41	205	3	EFO_0004145, GO_1903491
Disease	Congenital muscular dystrophy	ITGA7 LAMA2	3.03e-03	12	205	2	cv:C0699743
Disease	neovascular inflammatory vitreoretinopathy (is_marker_for)	BDNF FGF2	3.03e-03	12	205	2	DOID:9719 (is_marker_for)
Disease	progression free survival, response to carboplatin, methylcobalamin deficiency type cblE, ovarian serous carcinoma	ADAMTS17 USP7 EYS	3.11e-03	42	205	3	EFO_0004920, EFO_1001516, GO_0097328, MONDO_0009354
Disease	intraocular pressure measurement	CFAP95 ADAMTS17 PKHD1 FERMT2 PCDHGA5 GNB1L GAS7 EDA CSPG4 LPP	3.12e-03	509	205	10	EFO_0004695
Disease	lymphocyte count	CYP2C19 GAS6 RAP1GAP2 GPR87 LYST NRXN2 USP7 FGF2 DPAGT1 PLXDC1 PCDHGA9 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA1 PREX2 CD8A LPP CTSS ACOXL	3.14e-03	1464	205	20	EFO_0004587
Disease	feeling nervous measurement	ITIH1 PLEKHM1 BDNF CSMD1	3.21e-03	87	205	4	EFO_0009597
Disease	hereditary spastic paraplegia (implicated_via_orthology)	DNM1 DNM2 DNM3	3.32e-03	43	205	3	DOID:2476 (implicated_via_orthology)
Disease	carpal tunnel syndrome	ITIH1 MTMR11 ADAMTS17 HHIPL1	3.49e-03	89	205	4	EFO_0004143
Disease	squamous cell carcinoma, multiple keratinocyte carcinoma susceptibility measurement, basal cell carcinoma	PKHD1 CSMD1	3.56e-03	13	205	2	EFO_0000707, EFO_0004193, EFO_0007932
Disease	Hypoxanthine measurement	PKHD1 EDA	3.56e-03	13	205	2	EFO_0021604
Disease	eye disease	PCDHGA5 PRSS56 LAMA2	3.78e-03	45	205	3	EFO_0003966
Disease	ovarian serous carcinoma	PLEKHM1 MAGEC1 ACOXL	4.03e-03	46	205	3	EFO_1001516
Disease	Intellectual Disability	KMT2E BDNF FCSK NRXN2 SACS SLC35A2 IQSEC3 COL18A1 MACF1	4.23e-03	447	205	9	C3714756
Disease	Seizures	KMT2E BDNF FCSK HACE1 FGF2 MACF1	4.31e-03	218	205	6	C0036572
Disease	glaucoma	PKHD1 PCDHGA5 GNB1L GAS7 LPP	4.52e-03	154	205	5	MONDO_0005041
Disease	myopathy (implicated_via_orthology)	DNM2 FLNC COL18A1	4.54e-03	48	205	3	DOID:423 (implicated_via_orthology)
Disease	congenital disorder of glycosylation type I (implicated_via_orthology)	RFT1 ALG12	4.75e-03	15	205	2	DOID:0050570 (implicated_via_orthology)
Disease	Myopia	PRSS56 LAMA2	4.75e-03	15	205	2	C0027092
Disease	sitting height ratio	FGFR4 PRKD2 LINC02875	5.39e-03	51	205	3	EFO_0007118
Disease	Early infantile epileptic encephalopathy with suppression bursts	DNM1 ARX	5.41e-03	16	205	2	C0393706
Disease	glomerulonephritis (implicated_via_orthology)	GAS6 C6	6.10e-03	17	205	2	DOID:2921 (implicated_via_orthology)
Disease	platelet component distribution width	C2CD5 SEPTIN8 USP7 TUBA4B DNM1 ALG12 COL18A1 LPP DNM3 MACF1 EIF2AK4 ACOXL	6.80e-03	755	205	12	EFO_0007984
Disease	Congenital Fiber Type Disproportion	ITGA7 DNM2	6.83e-03	18	205	2	C0546264

Protein segments in the cluster

Peptide	Gene	Start	Entry
SGLAGHSVFLVPGLA	nan	76	A8MUN3
HFAFFETGVLGPGGR	MAMDC4	1021	Q6UXC1
LPDRIGHGTFLNSGE	ADAL	226	Q6DHV7
FSVHRIIGRGGFGEV	GRK3	191	P35626
HLLFGELRRGSGSFV	CNTNAP3	406	Q9BZ76
PFLEHIGPGARIIFF	AIG1	186	Q9NVV5
IGPGARIIFFGSTTI	AIG1	191	Q9NVV5
DRVDNFGSIPFGHGV	CYP27C1	471	Q4G0S4
FGSIPFGHGVRSCIG	CYP27C1	476	Q4G0S4
THSLGEGGFFRASPQ	ADAMTSL4	266	Q6UY14
GLAYPGVRTHGTLES	BDNF	31	P23560
PAFSRRIGFHFGVGD	CSMD1	1051	Q96PZ7
LEAGSLVYVHRGGPA	CSPG4	621	Q6UVK1
RTAAILHGGSPDFVG	EIF2AK4	221	Q9P2K8
HVPFLLIGGGTAAFA	AIFM1	131	O95831
DIILGGLFPIHFGVA	CASR	31	P41180
SFGTQIIGGREVIPH	GZMM	21	P51124
PVEFRGHAGSVRALF	FBXW10	446	Q5XX13
HIVINGSSFGADGFP	FGFR4	286	P22455
GFGIDSILSHRAGSP	BARHL1	6	Q9BZE3
HAGAGRFRFLGSILV	ABCA13	3411	Q86UQ4
GGAFPFTVGRISHGF	ACMSD	226	Q8TDX5
PFGVGALTHLLLSGS	ARMC5	636	Q96C12
PAAGGAVHTRGLDFA	CD8A	166	P01732
GLHPERVSYVLGATG	ADAM8	51	P78325
GLRGFFQVGSDLHLI	ADAM8	126	P78325
GFTPLILAATAGHVG	ANKRD17	1116	O75179
AFLGPGVLQATRTFH	ATP5PB	21	P24539
FYSGRVLGHPGSLVS	ADAMTS17	126	Q8TE56
FGGAIRNLGSPEHVT	ACOXL	61	Q9NUZ1
DHLEFPGVVPRTFLG	ALG12	56	Q9BV10
FSVHRIIGRGGFGEV	GRK2	191	P25098
PFIAGPVDIRHFFTG	RBM12B	11	Q8IXT5
HFFTGLTIPDGGVHI	RBM12B	21	Q8IXT5
TFGHFGSLGRVLLPE	RBM19	606	Q9Y4C8
FFLGVSGEPRFPSHL	RBM33	461	Q96EV2
GHGIAGPLIATAFTN	MSI2	311	Q96DH6
HLSPVLLGTFALSGG	RFT1	466	Q96AA3
HGVTPNLRGFFLVSG	AFMID	181	Q63HM1
RLAGVPASHFVGVDG	PCDHGA5	731	Q9Y5G8
PASHFVGVDGVRAFL	PCDHGA5	736	Q9Y5G8
TDPVTGRSRGFGFVL	HNRNPDL	181	O14979
LFSPLHALNFGIGGD	PAFAH1B3	61	Q15102
FVGGGSIRNVHSILP	MAMDC2	191	Q7Z304
FVPGLFGTSHGALQF	SLC25A32	186	Q9H2D1
PGSGQARFSVLLLHG	ABHD14B	26	Q96IU4
PVEFRGHAGSVRALF	FBXW10B	446	O95170
ERVTGLPATGFGAVF	CFAP95	126	Q5VTT2
HQVGLFGRLGSFPVR	NUP133	616	Q8WUM0
KTFSFLGFEIVRPGH	OAZ2	151	O95190
FSHGPTFPIIRLAGG	PRSS12	271	P56730
PGSHFVGVEGVRAFL	PCDHGA6	736	Q9Y5G7
GLGLLFAFTVHPNLG	KIDINS220	511	Q9ULH0
VHEGFELGTLAGPAF	PIP5KL1	91	Q5T9C9
GRPLLFSGSQSGLVH	GNB1L	36	Q9BYB4
HKFGTLGSRPGQFDR	TRIM71	641	Q2Q1W2
IGVRAGREHFAFGEP	MAGEC1	1026	O60732
FDIHILRAFGSLGPG	MAGED4	51	Q96JG8
GSVFIGGFPDLHGKI	EYS	2011	Q5T1H1
RTHGLLGQFFHPIGF	ITIH1	826	P19827
PLVIGHFNTASGVGF	MFSD9	166	Q8NBP5
HFNTASGVGFILGPV	MFSD9	171	Q8NBP5
GDERGFLGIAFHPSF	HHIPL1	246	Q96JK4
HPFLTRLGGTGASEE	MTMR11	416	A4FU01
LSAFGAHRGLGFGPE	MYO15A	546	Q9UKN7
GPEDSLLGTQSRGHF	GMIP	851	Q9P107
FVGRDFLPRGSGIVT	DNM1	51	Q05193
GTGIAPFIGFLQHRE	MTRR	546	Q9UBK8
LLHFTTGSDRVPVGG	HECTD2	706	Q5U5R9
PAGTRGGFVLNFHAD	JPH1	186	Q9HDC5
IVHVPFGTRGGEAVL	HLCS	316	P50747
FTGLRSITHFGRPPF	DUOX2	1481	Q9NRD8
FVGRDFLPRGSGIVT	DNM3	51	Q9UQ16
VRDVRFPTSLGGHGA	ENOSF1	11	Q7L5Y1
ETIISFPGGESLHGF	IDO2	166	Q6ZQW0
FPGGESLHGFILVTA	IDO2	171	Q6ZQW0
GFVATVTLIPAFRGH	DPAGT1	21	Q9H3H5
AHIFRIGPAPAFTGD	FBLN2	1101	P98095
LVAGAHALGEGQFPF	MTSS2	681	Q765P7
PTSHFVGVDGVRAFL	PCDHGA9	736	Q9Y5G4
GIHGLFGASTTRFLL	NLRP1	661	Q9C000
RLHTPSKFADFVLGG	NEMP2	371	A6NFY4
FHIRPATEGPGVLFA	COL18A1	511	P39060
LLRGRFAPSGHIEGF	FAM214B	356	Q7L5A3
ITIRFGGEHIPNSPF	FLNC	1716	Q14315
LLQFVTGSSRVPHGG	HACE1	831	Q8IYU2
TFGSKGAFGFQHPVR	RIPPLY3	66	P57055
RTGVPGGSEISFFFL	MEGF8	826	Q7Z7M0
DLTPSHQLEVGGGFR	KMT2E	1086	Q8IZD2
IPDIFIHGFTTRTGG	LACC1	186	Q8IV20
IHGFTTRTGGISYIP	LACC1	191	Q8IV20
PGSGVSFHIQIGLTR	PRKD2	41	Q9BZL6
HRSLDGIPFTVDAGG	LPP	506	Q93052
GFRILLHFSQTGAPG	GGA2	496	Q9UJY4
GRFTAVYDAGVPGHL	LAMA2	3006	P24043
FGFPTGLGALLVHNR	MOCOS	266	Q96EN8
PHFSGLAAGRTFLLQ	TUFM	11	P49411
FVGRDFLPRGSGIVT	DNM2	51	P50570
HGVRTGLFTPDLAFE	DNM2	396	P50570
RGFIPDTPIGVAHFL	IQSEC3	676	Q9UPP2
TLTFPFRIVHDAGFG	GPR87	91	Q9BY21
GSGVHGGLIILEPRF	PPFIBP2	741	Q8ND30
FAGGIVDPRTGHRLT	MACF1	1776	Q9UPN3
DFVAATSPGHIIIGG	GPRC6A	26	Q5T6X5
FEGPHGQSVAGLRFE	PCF11	956	O94913
PGSHFVGADGVRAFL	PCDHGA3	736	Q9Y5H0
PFLTRGGHAGTTYIF	NRXN2	81	P58401
RGFFLFVEGGRIDHG	ALPP	326	P05187
HDEFGRFGSSLTPLG	ITGA5	386	P08648
HTPDFFGSALRGGRD	ITGA5	451	P08648
GSPGHAFTLVGRLDS	FCSK	431	Q8N0W3
GGFLAGLPFSTIAKH	SLC37A4	376	O43826
GDFFEFGGVLRHPVI	EBLN1	276	P0CF75
HTTFFGAIRLGEAPA	EDA	376	Q92838
LVTFIGVGRDPHTFG	APBB3	361	O95704
PHTFGLIADLGRQSF	APBB3	371	O95704
TSGLRHVQLAFFPPG	CENPB	306	P07199
LHGSRLVPVYSGSGF	HTRA4	191	P83105
VTEGEFPSRIHLIGG	FBH1	761	Q8NFZ0
GVRFIFTLVGGHISP	ILVBL	66	A1L0T0
TVSRPLGADFRVHFG	CC2D2A	696	Q9P2K1
GEEFSGRGHFPLAER	CYP2C19	91	P33261
LFSKDHPRTGGERGF	EXT1	236	Q16394
LLGPISNHSFGGSFR	BRCA2	996	P51587
GFHFLAGEPRGEVLD	C6	196	P13671
LQGHRIPFGVIFGGT	GLT1D1	71	Q96MS3
RTFDPEGILLFAGGH	GAS6	326	Q14393
VSVAFGAPIGGVLFS	CLCN5	321	P51795
EHARGGFALGLPFGL	LINC02875	106	Q86X59
RGFLSAPVFAGTHSG	HOXD13	41	P35453
FAFLTGVGLGPALEF	TMBIM6	91	P55061
HEIGGTGIFVFLFAR	LYST	1806	Q99698
RRGHVGIFFIEGGVP	MS4A15	96	Q8N5U1
GLSTFLGAAVFRHPA	ARX	461	Q96QS3
GFFLRIHPDGRVDGV	FGF2	171	P09038
GPVSVGVDARHPSFF	CTSS	246	P25774
GEPGSLFGFSVALHR	ITGA7	46	Q13683
PEFGITHFIARFQGG	FERMT2	566	Q96AC1
RFGQFHLALSGGSSP	H6PD	581	O95479
GFGFKGSSFHRIIPQ	PPIE	181	Q9UNP9
RPGQGGFGELFRTHF	SAMM50	381	Q9Y512
GFASVHARLGGLTAP	SLC22A20P	461	A6NK97
AAGPLDTLHGRQGFF	SLC22A31	471	A6NKX4
PVHISGFFGLTDNRR	SACS	461	Q9NZJ4
RFSGLERSIVFGIHP	SLFN13	856	Q68D06
GVGAVFSLLFHLGTR	MFSD12	226	Q6NUT3
HFGGDPERITIFGSG	NLGN2	251	Q8NFZ4
FPRSTVPGHAGRLVF	PNP	56	P00491
LREEGGVSGFLHAFI	C2CD5	906	Q86YS7
VLGHGPRFISIAGLT	COL5A3	171	P25940
PRSRSLIVHFHGGGF	LIPE	641	Q05469
ELFSPLHALNFGIGG	PAFAH1B2	61	P68402
GRHVAFSGLVGLEPA	PRSS56	531	P0CW18
GVLVGLGHTPFIFSL	OR10C1	151	Q96KK4
IHVVPFSARGGRTLG	PARD3	286	Q8TEW0
HSGRVSEFVLLGFPA	OR6A2	6	O95222
PGSHFVGVDGVRAFL	PCDHGA1	736	Q9Y5H4
VLRSEPHGRFFGGTE	FSCN2	101	O14926
DPITGRSRGFGFVLF	HNRNPD	131	Q14103
VLALTHEGRFHPGLG	PTGFRN	196	Q9P2B2
SHGSPISGKLEGIFF	PHYHIPL	216	Q96FC7
GPAHSDGRFELVFSG	PLEKHM1	586	Q9Y4G2
RSIGLPDVHSGYGFA	RTCB	81	Q9Y3I0
LFFRPFRGVGTESGS	MRPS28	21	Q9Y2Q9
HGPGLLGSSIQTFEL	RTP5	271	Q14D33
GAPHFRFIIAGRQAG	TAF6L	556	Q9Y6J9
QSGFLAGGLHLVPSS	TMEM105	91	Q8N8V8
LFPRLHTGSEGQGDS	RAP1GAP2	566	Q684P5
SFIGNGVVIHLPGLF	ADSS1	96	Q8N142
FSPGTSFAGHLAGIL	RHBDD1	186	Q8TEB9
AVGAHLPASGLDIFG	SEC11C	6	Q9BY50
RPFHLVVFGASGFTG	SCCPDH	6	Q8NBX0
GGEALPFSHLILATG	AIFM2	96	Q9BRQ8
PGHGLETRVGSALFL	SERPINA4	131	P29622
VEFKPGLFHGVGFRS	GPRASP2	496	Q96D09
GLFHGVGFRSTSPFG	GPRASP2	501	Q96D09
PFSGERHGQGLRFAA	GAS7	11	O60861
GVGLTVGTPDFARRF	PIP4P2	206	Q8N4L2
PGAGGLAVRTFVSHF	NAGPA	71	Q9UK23
RFSGLERSIVFGIHP	SLFN11	856	Q7Z7L1
RLGFLLGEGIPSATH	TANC1	141	Q9C0D5
SHSTGFIEGVVGPAL	NUAK1	411	O60285
RLVHVFGAGFSPGNV	PKHD1	1751	P08F94
QGSTGAAGPRLFTIH	SMURF1	696	Q9HCE7
FGFHVDPLFALGAGL	SLC35A2	316	P78381
GTGSLVFALPHFTAG	SLCO4A1	181	Q96BD0
GLVAGLGHQEFARPS	TDGF1	26	P13385
LQGFLVFHSLGRGTG	TUBA4B	71	Q9H853
AFVVERGFGGITHGP	ACADVL	281	P49748
GLRIFGFIHPARDGD	B4GALNT4	166	Q76KP1
GDGHTDFVALLTGPR	CHRD	166	Q9H2X0
GLQDSFPARFGGIHF	CLVS2	186	Q5SYC1
PHGVFFRLGPSVVGL	PDCD11	1336	Q14690
PGSAGEAARAGHFTL	USP19	1046	O94966
HVGGLPLRFDSSGNV	TAS1R3	436	Q7RTX0
ISGALGLVLGHPFDT	SLC25A45	11	Q8N413
LGESGVFGNHSPLER	RNF148	56	Q8N7C7
HQSEGLRRFGGAFAP	PLCD3	121	Q8N3E9
GLLHALSFRDSPFGG	ARHGAP23	431	Q9P227
RAFHGLAGGTDVPFS	XYLB	476	O75191
PRSLSYGAIGVIVGH	PHEX	566	P78562
PRSLSLGGHVGFDSL	SEPTIN8	16	Q92599
PVNLHGRSALFGVFT	SEMA6C	306	Q9H3T2
APVTLTHTGLGAGIF	STAB2	2451	Q8WWQ8
GLGFQIRGFGPSVVH	PREX2	686	Q70Z35
PHSFRLEQGGTADGL	SART1	346	O43290
GRKSTPLHFAAGFGR	TNKS2	56	Q9H2K2
VHPLRAVGTEGLFGF	SLC35F6	206	Q8N357
LHRAPGFGFGIAISG	TJP1	26	Q07157
PSGLGFTRGDVFHVL	TJP3	491	O95049
FQAGSPGHLGVIRDF	ZBTB7C	211	A1YPR0
TFPITIIHGVFGAGK	ZGRF1	1646	Q86YA3
GFGVHRGAFLIPVAL	URB1-AS1	16	Q96HZ7
FHVSGKPFTFGEVGR	ZNF530	161	Q6P9A1
AHGTLFGPGQATRFF	ZNF746	306	Q6NUN9
HPLRQITIATGGFIF	PLXDC1	146	Q8IUK5
YRAGPTLSHGAIAGI	VSIG10L	766	Q86VR7
FFPHGGVIATGTRDG	WSB2	341	Q9NYS7
GAFHGTVDIVPSVGF	VGLL3	296	A8MV65
GTFGIPFLLRIHQGE	USP7	1001	Q93009
GLVAGLGHQEFARPS	TDGF1P3	26	P51864
GHKIVFAAGSPFLRD	ZBTB26	46	Q9HCK0
RGDDGGFFPRTLEIH	TM9SF1	221	O15321
SGHRRTVGEGFLFVL	USP54	1651	Q70EL1
GLFFTPTAVIRDFGG	NALCN	941	Q8IZF0
AHFDGILGLGFPILS	NAPSA	181	O96009
AEHGFGVRKLPFAEG	PCSK2	51	P16519